Archives for August 2007
Vermillion Closes $20.6 Million Equity Financing
Vermillion (formerly Ciphergen Biosystems), a Fremont, CA-based molecular diagnostics firm, has closed a $20.6 million equity financing with new and existing investors. The financing, which comes two weeks after the company received a non-compliance letter from Nasdaq, will be used to further Vermillion’s three leading development candidates.
The company’s most established development program is an […]
Indiana Seed Fund Invests in FlowCo
Indiana’s only life sciences seed-stage fund has invested $250,000 in FlowCo, a local company that’s developing a device that helps size and deliver stents more accurately. The company will use the money to create a human-use prototype for clinical trials scheduled to take place by next summer.
The device, developed by a biomedical engineer from Indianapolis, […]
CryoCor Completes Enrollment of A-Fib Trial
San Diego-based CryoCor has completed enrollment of the pivotal clinical study for using its Cryoabalation System to treat atrial fibrillation, bringing the company one step closer to its goal of U.S. approval for both a-fib and atrial flutter.
The Cryoabalation System, which uses extreme cold to destroy damaged cardiac tissue, was approved earlier this month for […]
Presenters Selected for AdvaMed 2007
AdvaMed, the industry trade association, has selected 22 emerging med tech companies to present at an inaugural conference, developed in part to create networking and partnering opportunities for its smaller member companies.
The event, AdvaMed 2007, will be held October 1-3 in Washington, D.C., and will cover such issues as Medicare, compliance, intellectual property, global market […]
Pittsburgh Partnership Backs Three Up and Comers
The Pittsburgh Life Sciences Greenhouse (PLSG), a public/private partnership founded in 2001 to grow Southwestern Pennsylvania’s life sciences industry, has added two local companies — Separation Design Group and ThermalTherapeutics Systems — to its expanding investment portfolio and contributed additional funding to a firm already under its wing, Applied Computational Technologies.
The bulk of the $450,000 […]
A+ for Mirabilis Medica
Mirabilis Medica, a three-year old startup based in Bothell, WA, has closed a $10.5 million extension to the Series A financing it completed a year ago. The funding — led by Arboretum Ventures of Ann Arbor, MI, and participated in by Split Rock Partners, Dow Venture Capital, and an individual investor — will be used […]
Signalife Completes $102 Million Financing
Signalife, a Greenville, SC, firm specializing in biomedical signal monitoring, has completed $102 million in financing — a much anticipated boost following the company’s June receipt of an AMEX deficiency letter stating that stockholder equity had fallen below the requirement for companies with market caps less than $50 million.
The company has received $2 million in […]
Minrad Appoints Two Senior Execs
Minrad, of Orchard Park, NY, today announced two senior-level appointments. Dennis Goupil was named senior vice president technical and Terence Vollrath was appointed vice president of operations.
Goupil joins Minrad from Biocure, an early stage medical device company based in Norcross, GA, where he was chief technology officer and VP of R&D. He’s also held posts […]
DiagnoCure Acquires Cancer Tests for $3 Million
DiagnoCure, a Quebec City company that sells cancer diagnostics, has acquired Worcester, MA-based Catalyst Oncology and its lead prognostic tests for breast, colon and potentially other cancers. DiagnoCure, which will pay $3 million upfront followed by future milestone payments, will take over development of the tests, including additional clinical studies.
The acquired tests already have been […]
West Michigan Life Sciences Sector on the Rise
According to The Grand Rapids Press, “West Michigan is on its way to attaining prominence in the life sciences industry.”
The paper, reporting this week on a just released study on attracting investment to the region, says, “Grand Rapids’ growing medical research capabilities, combined with Kalamazoo’s heritage of producing drugs and medical devices, create a critical […]
